These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1222 related articles for article (PubMed ID: 27665163)

  • 21. Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohort.
    Schonmann Y; Bleich O; Matalon A; Yeshua H
    Eur J Prev Cardiol; 2018 May; 25(8):870-880. PubMed ID: 29517367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.
    Mortensen MB; Fuster V; Muntendam P; Mehran R; Baber U; Sartori S; Falk E
    J Am Coll Cardiol; 2016 Aug; 68(9):881-91. PubMed ID: 27561760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
    J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 2013 ACC/AHA cardiovascular prevention guidelines improve alignment of statin therapy with coronary atherosclerosis as detected by coronary computed tomography angiography.
    Pursnani A; Mayrhofer T; Ferencik M; Hoffmann U
    Atherosclerosis; 2014 Nov; 237(1):314-8. PubMed ID: 25299966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary artery calcium scoring for individualized cardiovascular risk estimation in important patient subpopulations after the 2019 AHA/ACC primary prevention guidelines.
    Dzaye O; Dudum R; Reiter-Brennan C; Kianoush S; Tota-Maharaj R; Cainzos-Achirica M; Blaha MJ
    Prog Cardiovasc Dis; 2019; 62(5):423-430. PubMed ID: 31715194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.
    Mortensen MB; Afzal S; Nordestgaard BG; Falk E
    J Am Coll Cardiol; 2015 Dec; 66(24):2699-2709. PubMed ID: 26700832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.
    Pagidipati NJ; Navar AM; Mulder H; Sniderman AD; Peterson ED; Pencina MJ
    JAMA; 2017 Apr; 317(15):1563-1567. PubMed ID: 28418481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility Trial.
    Muhlestein JB; Knowlton KU; Le VT; Lappe DL; May HT; Min DB; Johnson KM; Cripps ST; Schwab LH; Braun SB; Bair TL; Anderson JL
    JACC Cardiovasc Imaging; 2022 May; 15(5):843-855. PubMed ID: 34922872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
    Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
    Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis.
    Hong JC; Blankstein R; Shaw LJ; Padula WV; Arrieta A; Fialkow JA; Blumenthal RS; Blaha MJ; Krumholz HM; Nasir K
    JACC Cardiovasc Imaging; 2017 Aug; 10(8):938-952. PubMed ID: 28797417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.
    Mortensen MB; Tybjærg-Hansen A; Nordestgaard BG
    JAMA Cardiol; 2022 Aug; 7(8):836-843. PubMed ID: 35793078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary artery calcium score improves cardiovascular risk prediction in persons without indication for statin therapy.
    Möhlenkamp S; Lehmann N; Greenland P; Moebus S; Kälsch H; Schmermund A; Dragano N; Stang A; Siegrist J; Mann K; Jöckel KH; Erbel R;
    Atherosclerosis; 2011 Mar; 215(1):229-36. PubMed ID: 21251655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular Risk and Statin Eligibility in Primary Prevention: A Comparison between the Brazilian and the AHA/ACC Guidelines.
    Cesena FHY; Valente VA; Santos RD; Bittencourt MS
    Arq Bras Cardiol; 2020 Sep; 115(3):440-449. PubMed ID: 33027365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of application of 2013 ACC/AHA guideline and 2011 European Society of Cardiology guideline for the management of dyslipidemias for primary prevention in a Turkish cohort.
    Yılmaz M; Atar İ; Hasırcı S; Akyol K; Tekin A; Karaçağlar E; Çiftçi O; Müderrisoğlu H
    Anatol J Cardiol; 2017 Feb; 17(2):92-96. PubMed ID: 27684519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study.
    Bittencourt MS; Blankstein R; Blaha MJ; Sandfort V; Agatston AS; Budoff MJ; Blumenthal RS; Krumholz HM; Nasir K
    Eur J Prev Cardiol; 2018 Nov; 25(17):1887-1898. PubMed ID: 30043629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of statin guidelines on statin utilization and costs in an employer-based primary care clinic.
    Gurgle HE; Schauerhamer MB; Rodriguez SA; McAdam-Marx C
    Am J Manag Care; 2017 Dec; 23(12):e387-e393. PubMed ID: 29261246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.